The Pheo Para Alliance announced that PRRT trials for pheo/para patients have begun at the National Cancer Institute, a division of the National Institutes of Health in Washington, D.C. More information on this important clinical trial can be found here.
The alliance, which was formed by the merger of the Pheo Para Alliance and the Pheo Para Troopers into a single organization, has chosen patient advocacy for its major focus.
That intention was formally announced at ISP 2017 in Sydney, Australia (30 August-3 September 2017). The Pheo Para Alliance – a silver-level sponsor of the event, has begun posting videos of conference presentations on its website.